Gene therapy hope for sickle cell Anti-sickling gene

A potential medical breakthrough that could give hope to an estimated 90,000 sickle cell anemia or sickle cell disease patients in the U.S. — sickle cell being a genetic blood disorder of the red blood cells that mostly affects people of sub-Saharan African descent — has been signaled by scientists at UCLA as a stem cell gene therapy moves towards clinical trials.

Read more:
Sickle cell gene therapy advances to clinical trials

 
















Source: LA Wave

Art and Science of Laboratory Medicine

Facebook: www.facebook.com/LaboratoryEQAS

Twitter: LaboratoryEQAS.